Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms

Summary: Activated macrophages and their inflammatory products play a key role in innate immunity and in pathogenesis of autoimmune/inflammatory diseases. Macrophage activation needs to be tightly regulated to rapidly mount responses to infectious challenges but to avoid toxicity associated with excessive activation. Rapid and potent macrophage activation is driven by cytokine‐mediated feedforward loops, while excessive activation is prevented by feedback inhibition. Here we discuss feedforward mechanisms that augment macrophage responses to Toll‐like receptor (TLR) ligands and cytokines that are mediated by signal transducer and activator of transcription 1 (STAT1) and induced by interferon‐γ (IFN‐γ). IFN‐γ also drives full macrophage activation by inactivating feedback inhibitory mechanisms, such as those mediated by interleukin‐10 (IL‐10), and STAT3. Priming of macrophages with IFN‐γ reprograms cellular responses to other cytokines, such as type I IFNs and IL‐10, with a shift toward pro‐inflammatory STAT1‐dominated responses. Similar but partially distinct priming effects are induced by other cytokines that activate STAT1, including type I IFNs and IL‐27. We propose a model whereby opposing feedforward and feedback inhibition loops crossregulate each other to fine tune macrophage activation. In addition, we discuss how dysregulation of the balance between feedforward and feedback inhibitory mechanisms can contribute to the pathogenesis of autoimmune and inflammatory diseases, such as rheumatoid arthritis and systemic lupus erythematosus.

[1]  C. Biron,et al.  A Role for IFN-αβ in Virus Infection-Induced Sensitization to Endotoxin1 , 2001, The Journal of Immunology.

[2]  Xiaoxia Li,et al.  Modulation of Toll–interleukin 1 receptor mediated signaling , 2005, Journal of Molecular Medicine.

[3]  A. Tarakhovsky,et al.  IFN-α Priming Results in a Gain of Proinflammatory Function by IL-10: Implications for Systemic Lupus Erythematosus Pathogenesis1 , 2004, The Journal of Immunology.

[4]  J. Woodgett,et al.  IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. , 2006, Immunity.

[5]  M. Shinohara,et al.  Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. , 2008, Immunity.

[6]  D. Levy,et al.  Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.

[7]  Bali Pulendran,et al.  Lipopolysaccharides from Distinct Pathogens Induce Different Classes of Immune Responses In Vivo1 , 2001, The Journal of Immunology.

[8]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[9]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[10]  D. Klinman.  Does activation of the innate immune system contribute to the development of rheumatoid arthritis? , 2003, Arthritis and rheumatism.

[11]  Kozo Nakamura,et al.  RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β , 2002, Nature.

[12]  T. Taniguchi,et al.  A weak signal for strong responses: interferon-alpha/beta revisited , 2001, Nature Reviews Molecular Cell Biology.

[13]  D. Kono,et al.  Inhibition of Lupus by Genetic Alteration of the Interferon-α/β Receptor , 2003 .

[14]  R. Friedman,et al.  Interferon production in patients with systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[15]  Virginia Pascual,et al.  Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.

[16]  A. Billiau,et al.  Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. , 1997, Journal of immunology.

[17]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[18]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[20]  T. van der Poll,et al.  Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. , 1997, Journal of immunology.

[21]  R. Young,et al.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.

[22]  Ash A. Alizadeh,et al.  Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. , 2003, Arthritis and rheumatism.

[23]  C. Biron.  Interferons α and β as Immune Regulators—A New Look , 2001 .

[24]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.

[25]  P. Gregersen,et al.  The emerging role of interferon in human systemic lupus erythematosus. , 2004, Current opinion in immunology.

[26]  T. Hirano,et al.  IL-6 signal transduction and its physiological roles: the signal orchestration model. , 2003, Reviews of physiology, biochemistry and pharmacology.

[27]  Persistent Mitochondrial Hyperpolarization, Increased Reactive Oxygen Intermediate Production, and Cytoplasmic Alkalinization Characterize Altered IL-10 Signaling in Patients with Systemic Lupus Erythematosus1 , 2002, The Journal of Immunology.

[28]  R. Coffman,et al.  Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. , 1995, Science.

[29]  T. Taniguchi,et al.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. , 2000, Nature.

[30]  D. Kono,et al.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity , 2001, Arthritis research.

[31]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[32]  W. B. van den Berg,et al.  Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. , 2001, Arthritis and rheumatism.

[33]  I. Wang,et al.  IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Ming Yan,et al.  Protein ISGylation modulates the JAK-STAT signaling pathway. , 2003, Genes & development.

[35]  S. Huang,et al.  High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. , 1997, Journal of immunology.

[36]  L. Ivashkiv,et al.  The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? , 2003, Arthritis and rheumatism.

[37]  Allan Randrup Thomsen,et al.  Viral Infection Causes Rapid Sensitization to Lipopolysaccharide: Central Role of IFN-αβ1 , 2001, The Journal of Immunology.

[38]  Xiaoyu Hu,et al.  Sensitization of IFN-γ Jak-STAT signaling during macrophage activation , 2002, Nature Immunology.

[39]  C. Biron,et al.  A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin. , 2001, Journal of immunology.

[40]  Lionel B Ivashkiv,et al.  Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. , 2002, Nature immunology.

[41]  M. Caligiuri,et al.  The role of STAT1 in viral sensitization to LPS , 2003, Journal of endotoxin research.

[42]  R. Warrington,et al.  Interleukin‐10 Response Abnormalities in Systemic Lupus Erythematosus , 1997, Scandinavian journal of immunology.

[43]  M. Crow.  Interferon-alpha: a new target for therapy in systemic lupus erythematosus? , 2003, Arthritis and rheumatism.

[44]  L. Ivashkiv.  Type I Interferon Modulation of Cellular Responses to Cytokines and Infectious Pathogens: Potential Role in SLE Pathogenesis , 2003, Autoimmunity.

[45]  V. Pascual,et al.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.

[46]  P. Hart,et al.  Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. , 1995, Immunology.

[47]  S. Akira,et al.  Activation and regulation of Toll-like receptors 2 and 1 in human leprosy , 2003, Nature Medicine.

[48]  P. Paik,et al.  Amplification of IFN-α-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors , 2004, Nature Immunology.

[49]  T. Hamilton,et al.  The cell biology of macrophage activation. , 1984, Annual review of immunology.

[50]  B. Pulendran,et al.  Cutting Edge: Different Toll-Like Receptor Agonists Instruct Dendritic Cells to Induce Distinct Th Responses via Differential Modulation of Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase and c-Fos 1 , 2003, The Journal of Immunology.

[51]  J. Darnell,et al.  Stat3 Recruitment by Two Distinct Ligand-induced, Tyrosine-phosphorylated Docking Sites in the Interleukin-10 Receptor Intracellular Domain* , 1996, The Journal of Biological Chemistry.

[52]  George D. Kalliolias,et al.  IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p381 , 2008, The Journal of Immunology.

[53]  M. Odeh,et al.  Role of cytokines in rheumatoid arthritis. , 1998, Drug news & perspectives.

[54]  T. Owens,et al.  Interferon‐γ confers resistance to experimental allergic encephalomyelitis , 1996, European journal of immunology.

[55]  L. Ivashkiv,et al.  Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. , 2006, Arthritis and rheumatism.

[56]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[57]  R. Salomon,et al.  Critical Role for STAT4 Activation by Type 1 Interferons in the Interferon-γ Response to Viral Infection , 2002, Science.

[58]  T. van der Poll,et al.  Proinflammatory Effects of IL-10 During Human Endotoxemia1 , 2000, The Journal of Immunology.

[59]  M. Marino,et al.  Effect of Pro-inflammatory/Anti-inflammatory Agents on Cytokine Secretion by Peripheral Blood Mononuclear Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus , 2003, Autoimmunity.

[60]  Simmie L. Foster,et al.  Gene-specific control of inflammation by TLR-induced chromatin modifications , 2008, Nature.

[61]  Kathleen A. Kennedy,et al.  Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4 , 2006, Nature.

[62]  L. Ivashkiv,et al.  Crosstalk among Jak‐STAT, Toll‐like receptor, and ITAM‐dependent pathways in macrophage activation , 2007, Journal of leukocyte biology.

[63]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[64]  E. Raz,et al.  Cutting Edge: Activation of Toll-Like Receptor 2 Induces a Th2 Immune Response and Promotes Experimental Asthma1 , 2004, The Journal of Immunology.

[65]  D. Olive,et al.  IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. , 2003, Journal of immunology.

[66]  A. Tarakhovsky,et al.  Inhibition of Interleukin 10 Signaling after Fc Receptor Ligation and during Rheumatoid Arthritis , 2003, The Journal of experimental medicine.

[67]  S. Smith,et al.  Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. , 1995, Blood.

[68]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[69]  Z. Tian,et al.  Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. , 2002, The Journal of clinical investigation.

[70]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[71]  C. Hidaka,et al.  Homeostatic Role of Interferons Conferred by Inhibition of IL-1-Mediated Inflammation and Tissue Destruction , 2005, The Journal of Immunology.

[72]  G. G. Choudhury.  A linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase Cepsilon, and MAPK in mesangial cells regulates interferon-gamma-induced STAT1alpha transcriptional activation. , 2004, The Journal of biological chemistry.

[73]  T. Asano,et al.  PI3K-mediated negative feedback regulation of IL-12 production in DCs , 2002, Nature Immunology.

[74]  L. Ivashkiv.  Cytokine expression and cell activation in inflammatory arthritis. , 1996, Advances in immunology.

[75]  G. G. Choudhury.  A Linear Signal Transduction Pathway Involving Phosphatidylinositol 3-Kinase, Protein Kinase Cϵ, and MAPK in Mesangial Cells Regulates Interferon-γ-induced STAT1α Transcriptional Activation* , 2004, Journal of Biological Chemistry.

[76]  G. Cheng,et al.  The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. , 2008, The Journal of clinical investigation.

[77]  S. Smale,et al.  Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. , 2006, Genes & development.

[78]  M. Crow.  Interferon-α: A new target for therapy in systemic lupus erythematosus? , 2003 .

[79]  T. Taniguchi,et al.  Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. , 2003, Genes & development.

[80]  R. Jope,et al.  Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 , 2005, Nature Immunology.

[81]  D. Isenberg,et al.  Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. , 2000, Arthritis and rheumatism.

[82]  J. Fung,et al.  High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. , 1997, Transplantation proceedings.

[83]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.

[84]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[85]  R. Schreiber,et al.  Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.

[86]  C. Hawrylowicz,et al.  Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.

[87]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[88]  M. Crow.  Type I interferon and autoimmune disease. , 2003, Autoimmunity.

[89]  J. Renauld.  Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators , 2003, Nature Reviews Immunology.

[90]  L. Ivashkiv,et al.  Lipopolysaccharide-Induced Expression of Matrix Metalloproteinases in Human Monocytes Is Suppressed by IFN-γ via Superinduction of ATF-3 and Suppression of AP-11 , 2008, The Journal of Immunology.

[91]  G. Camussi,et al.  IL‐10 stimulates production of platelet‐activating factor by monocytes of patients with active systemic lupus erythematosus (SLE) , 2000, Clinical and experimental immunology.

[92]  K. Winestock,et al.  IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. , 1995, Journal of immunology.

[93]  Kathleen M. Smith,et al.  Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.

[94]  T. Taniguchi,et al.  Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. , 2000, Science.

[95]  A. Koch,et al.  Macrophages and their products in rheumatoid arthritis , 2007, Current opinion in rheumatology.

[96]  R. Friedman,et al.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. , 1982, Science.

[97]  F. Sallusto,et al.  Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. , 2007, Nature immunology.

[98]  Xiaoyu Hu,et al.  Reprogramming of IL-10 Activity and Signaling by IFN-γ 1 , 2003, The Journal of Immunology.

[99]  Yulan Qing,et al.  Alternative Activation of STAT1 and STAT3 in Response to Interferon-γ* , 2004, Journal of Biological Chemistry.

[100]  Egil Lien,et al.  Injury Primes the Innate Immune System for Enhanced Toll-Like Receptor Reactivity1 , 2003, The Journal of Immunology.

[101]  S. Teitelbaum,et al.  Bone resorption by osteoclasts. , 2000, Science.

[102]  S. Koyasu,et al.  PI3K and negative regulation of TLR signaling. , 2003, Trends in immunology.

[103]  T. Taniguchi,et al.  Activation of the Transcription Factor ISGF3 by Interferon-gamma , 1999, Biological chemistry.

[104]  R. Price,et al.  Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. , 2002, Arthritis and rheumatism.

[105]  S. Saccani,et al.  p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. , 2002, Nature immunology.

[106]  M. Crow.  IntroductionType I Interferon and Autoimmune Disease , 2003 .

[107]  W. B. van den Berg,et al.  Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. , 2004, Arthritis and rheumatism.

[108]  R. Baron,et al.  'Tuning' of type I interferon–induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages , 2008, Nature Immunology.

[109]  G. Sturfelt,et al.  Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies , 2000, Lupus.

[110]  D. Choubey,et al.  Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice , 2003, The Journal of experimental medicine.

[111]  S. Akira,et al.  Interleukin-10 Receptor Signaling through the JAK-STAT Pathway , 1999, The Journal of Biological Chemistry.

[112]  C. Biron.  Interferons alpha and beta as immune regulators--a new look. , 2001, Immunity.

[113]  T. Gingeras,et al.  Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. , 2001, The Journal of experimental medicine.

[114]  C. Hunter,et al.  Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii , 1997, Infection and immunity.

[115]  D. Cohen,et al.  IL‐10 receptor dysfunction in macrophages during chronic inflammation , 2001, Journal of leukocyte biology.

[116]  D. Kono,et al.  Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor. , 2003, Autoimmunity.

[117]  L. Ivashkiv.  A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways , 2008, Nature Reviews Immunology.

[118]  R. Medzhitov.  Recognition of microorganisms and activation of the immune response , 2007, Nature.

[119]  G. Firestein,et al.  How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. , 2002, Arthritis and rheumatism.

[120]  G. Illei,et al.  Monocyte response to Th1 stimulation and effector function toward human mesangial cells are not impaired in patients with lupus nephritis. , 2003, Clinical immunology.

[121]  W. Cowden,et al.  IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. , 1996, Journal of immunology.

[122]  T. Gingeras,et al.  Reprogramming of the Macrophage Transcriptome in Response to Interferon-γ and Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.